Mersana therapeutics, inc. (MRSN)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Dec'16
ASSETS
Current assets:
Cash and cash equivalents

60,450

62,351

58,196

116,206

137,279

59,634

61,604

51,142

32,354

26,591

50,756

33,053

100,297

Short-term marketable securities

17,976

37,439

53,806

11,971

-

10,497

24,455

45,367

75,605

88,143

-

-

-

Short-term marketable securities

-

-

-

-

-

-

-

-

-

-

82,622

44,179

-

Accounts receivable

-

-

298

288

468

459

586

1,681

288

784

731

513

1,051

Prepaid expenses and other current assets

1,866

1,536

2,397

3,151

3,326

3,715

3,404

3,995

3,111

2,025

2,616

1,815

825

Total current assets

80,292

101,326

114,697

131,616

141,073

74,305

90,049

102,185

111,358

117,543

136,725

79,560

102,173

Property and equipment, net

1,979

2,164

2,446

2,755

2,868

2,694

2,525

2,753

2,593

2,319

2,325

2,373

2,483

Operating lease right-of-use assets

12,134

2,598

3,059

3,508

3,944

-

-

-

-

-

-

-

-

Long-term marketable securities

-

-

-

-

-

-

-

-

-

10,482

-

-

-

Long-term marketable securities

-

-

-

-

-

-

-

-

-

-

3,482

-

-

Other assets

1,453

1,453

1,453

1,503

1,503

1,503

1,804

1,970

1,804

371

384

3,283

431

Total assets

95,858

107,541

121,655

139,382

149,388

78,502

94,378

106,908

115,755

130,715

142,916

85,216

105,087

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

4,603

7,296

7,304

6,517

6,965

10,727

6,729

4,158

2,522

3,070

3,215

1,862

2,068

Accrued expenses

5,678

8,986

8,037

9,761

7,938

12,375

10,512

8,494

5,912

6,944

4,607

4,496

3,428

Deferred rent

-

-

-

-

-

-

48

-

-

232

215

198

159

Deferred revenue

4,804

4,815

4,646

5,481

5,604

46,196

14,151

19,224

20,903

21,635

-

-

-

Operating lease liabilities

1,150

2,219

2,145

2,074

2,005

-

-

-

-

-

-

-

-

Short-term debt

1,167

667

167

-

-

-

-

-

-

-

-

-

-

Other liabilities

88

87

85

84

83

127

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

16,476

24,870

22,731

Total current liabilities

17,490

24,070

22,384

23,917

22,595

69,425

31,440

31,876

29,337

31,881

24,513

31,426

28,386

Operating lease liabilities

11,295

677

1,257

1,823

2,375

-

-

-

-

-

-

-

-

Long-term debt, net

3,732

4,201

4,670

4,805

-

-

-

-

-

-

-

-

-

Other liabilities

250

275

299

323

346

282

-

-

-

-

-

-

-

Deferred rent, net of current portion

-

-

-

-

-

-

328

355

312

67

128

189

299

Deferred revenue, net of current portion

-

-

-

-

-

-

32,756

28,984

29,559

28,773

-

-

-

Total liabilities

32,767

29,223

28,610

30,868

25,316

69,707

64,524

-

-

60,721

-

-

-

Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

-

-

34,633

30,806

37,571

Commitments (Note 12)

-

-

-

-

-

-

0

0

0

-

0

0

0

Stockholders' equity
Preferred stock, $0.0001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

-

-

-

-

-

-

0

0

0

-

0

-

0

Common stock, $0.0001 par value; 175,000,000 shares authorized; 48,006,049 and 45,388,023 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

5

5

5

5

5

3

3

3

3

3

3

1

1

Additional paid-in capital

272,390

270,662

269,140

267,834

266,332

172,966

171,627

170,446

169,018

168,018

167,565

4,532

3,551

Accumulated other comprehensive income (loss)

-4

25

28

11

-

-8

-42

-90

-162

-149

-15

-9

-

Accumulated deficit

-209,300

-192,374

-176,128

-159,336

-142,265

-164,166

-141,734

-124,666

-112,312

-97,878

-83,911

-76,179

-59,171

Total stockholders’ equity

63,091

78,318

93,045

108,514

124,072

8,795

29,854

45,693

56,547

69,994

83,642

-71,655

-55,619

Total liabilities and stockholders’ equity

95,858

107,541

121,655

139,382

149,388

78,502

94,378

106,908

115,755

130,715

142,916

85,216

105,087